For veterinary hospitals, keeping 503B manufactured drugs on-hand for office use and dispensing is critical to top-quality patient care. But stocking these manufactured products provides another opportunity for veterinary staff—building stronger client relationships.
With 503B drugs on hand, you can deepen client relationships in ways that can’t be replaced by online pharmacies. It gives you the opportunity to provide the highest quality medication, consulting services on storage and administration, and added convenience. Below we take a deeper dive into three important ways your 503B medication stock will improve vet-client relationships and build loyalty for your practice.
By federal law, veterinary hospitals can legally stock and dispense our manufactured drugs. Traditional 503A compounding pharmacies were never intended to provide office stock as the intent was to provide individual patient prescriptions.
Quality builds trust and loyalty
It’s common for online retailers, unauthorized pharmacies, and street vendors to sell counterfeit pet medications—often at a large discount—that resemble the real thing. Sadly, over 1 in 10 pet owners have been duped by online counterfeit pet medications. These imitations pose a real threat to pets because of their incorrect dosing, unknown active ingredients, or no ingredients at all.
Offering reliable, high-quality medications to your clients directly from your practice increases client confidence and trust. You and your client can come out of an appointment knowing the medication is coming from a reputable source where products are manufactured with extensive testing for purity and stability, meets their pet’s needs, and it’s in a dosage form or flavor that makes at-home treatment easier.
According to a study published in the Journal of the American Veterinary Medical Association, clients are 40% more likely to follow veterinary recommendations when communication is clear, thorough, and trustworthy. That’s why it’s so important to be thorough with the information you share about treatment recommendations and medication instructions. It provides a great opportunity to educate pet owners on reputable pharmacies.
Reinforce your consultative role
Veterinarians are the people whom pet owners trust the most, influenced more by the knowledge, quality of care, and compassion given than by price or convenience. Having a positive relationship with a pet owner creates better opportunities to counsel clients on proper medication storage and usage.
To further the trust between the vet and the client, the relationship should exist beyond the appointment. A follow-up phone call regarding at-home treatment enhances the level of care and helps a client know they can depend on their veterinary staff. Research shows one of the main reasons clients switch vets is due to confusing communication and treatment recommendations. Following through, providing clarity, and fostering a consultative role will strengthen the overall relationship you have with your clients.
Meet pet owners’ needs for convenience
Speed and convenience are essential to nearly any customer experience in today’s increasingly fast-paced world. Retail sales of pet medication purchased online has grown to 16% and allowed online pharmacies to successfully draw from this revenue stream for veterinary hospitals and clinics.
However, by stocking manufactured 503B drugs, veterinary practices can recoup some of this revenue by making high-quality medications readily available to clients. When a client can walk out of the vet’s office with the exact medication they need to give their pet, it eliminates the need to wait on a local (503A) compounding pharmacy or to find a reputable online pharmacy, which may or may not be experiencing a shortage.
Direct dispensing also reduces the stress vet visits can cause for both pets and owners. After diagnosing, explaining, and setting expectations for the new medication with the client, at-home treatment education can get lost in the information overload. With the drug in-house and handed directly to the pet owner, you can take the time to reinforce administration guidance.
Take advantage of ordering with Epicur. All drugs are ready to ship same day with 1-2 days in transit.
When a pet owner walks out the door with no medication in hand, they have many other options where they could purchase their needed veterinary pharmaceuticals. Other well-known stores such as Walmart, PetRx, and Chewy Rx are popular for pet food, supplies, and now pet medications, where clients can fill their prescriptions instead.
Keeping 503B medications in stock helps you provide the safest, highest-quality treatment while reinforcing your trusted relationship.
Partner with Epicur for your bulk stock and dispensing.
Call us at 888-508-5032 to start your order!
More to Read
Why Quality Matters in Compounded Veterinary Ophthalmology Medications
What Should Veterinarians Know About Ophthalmic Eye Drops? Quality matters in every veterinary medication, but when it comes to ophthalmic medications, the stakes are even higher. Eyesight plays a critical role in an animal’s quality of life, and veterinary professionals know that even the slightest variation in ophthalmic preparations can impact healing, comfort, and outcomes. When veterinary ophthalmic medications fail to meet basic standards of quality and consistency, the consequences can extend far beyond the patient. They can influence treatment outcomes, client trust, and confidence in your medication provider. Dr. DJ Haeussler (BS, MS, DVM, DACVO) has seen firsthand how low-quality eye drops can negatively impact patient outcomes and the veterinarian-client relationship. From delayed healing to frustrated pet owners, the ripple effects of unreliable medications are real—and preventable. He helps us break down the common problems with compounded veterinary ophthalmology products today and what to look for in your products and medication partner. Only have 3 minutes? Watch the highlights from our interview with Dr. Haeussler. https://vimeo.com/1191194793/c1c371f5dd?fl=ip&fe=ec What problems are veterinarians seeing with eye drops? Veterinary ophthalmology often relies on compounded medications to meet specific clinical needs. However, not all compounded products are created equal. Many veterinary professionals have experienced challenges with compounded ophthalmic medications, including: Changing formulations without clear communication Inconsistent beyond-use dating Variability in potency or effectiveness Unpredictable stability once dispensed Patient discomfort during administration These issues can make it difficult to determine whether a treatment failure is due to disease progression or the medication itself. There have been many cases where variability in formulation or quality has led to stinging or irritation in the patient’s eyes, complicating treatment compliance even further. In ophthalmology, where precision matters, even small inconsistencies can lead to delayed healing, increased follow-ups, and client frustration—especially when treatment becomes uncomfortable or difficult to administer. Looking for ways to evaluate your medication provider? We’ve got tips for that. I want to know those 5 best qualities Why is consistency important in veterinary ophthalmology medications? Consistency is not just a preference—it is a clinical necessity. Unlike many systemic treatments, ophthalmic medications are applied directly to sensitive tissues, which means they must meet high standards in: Sterility – to prevent ocular infection Potency accuracy – to ensure effective dosing Stability – to maintain performance over time Variability in traditional compounding (503A pharmacies) can lead to differences between batches, while manufacturing under stricter regulations with process control can reduce those risks and support more predictable outcomes. For veterinary teams, that reliability translates into greater confidence in prescribing and clearer expectations for patient response. How do compounded veterinary medications vary in quality standards? Not all compounding environments operate under the same level of oversight or manufacturing rigor. Traditional compounding approaches can introduce variability in potency, sterility, and consistency from one preparation to the next. By contrast, 503B manufacturing facilities are designed to produce compounded medications at scale under current Good Manufacturing Practices (cGMP), with an emphasis on batch consistency and quality control. This distinction matters, especially for medications used frequently in practice or across multiple patients. In fact, when a medication is not available through a commercial manufacturer, guidance often points clinicians toward 503B products as a higher-quality alternative due to their greater consistency and reduced variability compared to traditional compounding. How does packaging impact ophthalmic drug quality? Quality doesn’t stop at formulation. Packaging can also play a major role in quality. Many ophthalmic medications, including tacrolimus eye drops, are highly sensitive to light exposure. Improper packaging can lead to: Drug degradation Reduced potency Shortened shelf life Less predictable dosing If the appropriate packaging is not used in the manufacturing process, the quality of the product is at risk before it even reaches the patient. Opaque bottles help protect light-sensitive products from light, aiding in drug stability and supporting consistent performance and reducing waste for veterinary practices. If you’re receiving eye drops in clear bottles, that’s a warning sign to consider the quality of the product you’re receiving. Packaging Matters! Read more about how packaging affects medication quality. I need to know the details about packaging quality. What should veterinarians look for in an ophthalmic medication provider? For veterinary professionals, choosing an ophthalmic product isn’t just about availability—it’s about trust. You and your practice need to trust that: The formulation will remain consistent over time The beyond-use dating reflects real stability data The medication will perform reliably across patients The manufacturer is transparent and accountable Your provider should be able to confirm the quality of their products and reinforce your trust in them. Key indicators of quality include proven safety standards, batch-to-batch consistency, verified potency and label accuracy, reliable inventory and dating, transparency and support. 503A pharmacies are not required to conduct final product testing. They also have shorter USP limited-beyond-use dates compared to stability-indicating beyond-use dates. Compounded medications are not generics. Products from different facilities containing the same active ingredient often differ in formulation, testing, regulatory requirements, and dating. Variations between 503A and 503B facilities and among individual compounding pharmacies can negatively impact quality, consistency, and the animal’s overall health. How Epicur sets a higher standard for ophthalmic medications. Epicur’s approach to veterinary ophthalmic medications is centered on reducing variability and increasing confidence. As a 503B outsourcing facility, Epicur follows current Good Manufacturing Practices (cGMP)—which requires final product testing including sterility, potency, pH, content uniformity, disintegration and more. This allows for: Greater batch consistency Validated stability and longer, proven expiration dates of up to 365 days Reduced variability compared to traditional compounding Additionally, Epicur prioritizes packaging decisions that support drug integrity, including opaque containers for light-sensitive ophthalmic medications, with testing performed both before and after packaging to verify stability and purity. This combination of manufacturing rigor and thoughtful product design helps veterinary professionals prescribe with confidence and gives pet owners peace of mind. Together, we can set a higher standard for ophthalmic care. By prioritizing consistency, sterility, stability, and transparency, practices can reduce uncertainty and focus on what matters most: delivering better care and
Meet Jordan Ricketts: Building Meaningful Partnerships with Veterinary Teams
Meet Jordan Ricketts, Southeast Specialty Representative for Epicur. Jordan brings a unique blend of scientific curiosity, deep veterinary-family roots, and a genuine love for relationship building. Get to know more about Jordan and the insight, care, and commitment she brings to the Epicur team.
The Referral Dilemma: Choosing the Best Partners in Veterinary Medicine
The following blog is written by Epicur Pharma’s Advisory Council member Debbie Boone, BS, CVPM. With over 23 years of in-clinic experience managing AAHA-accredited hospitals, Debbie understands the processes and systems a thriving practice must have in place – and what it takes to implement them. Debbie shares her perspective on referrals, and how veterinary professionals can ensure integrity and reliability through careful selection of the companies they utilize and endorse for crucial medications.